BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1004 related articles for article (PubMed ID: 15955168)

  • 1. Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation.
    Moriyama T; Nitta K; Suzuki K; Honda K; Horita S; Uchida K; Yumura W; Tanabe K; Toma H; Nihei H; Yamaguchi Y
    Clin Transplant; 2005; 19 Suppl 14():41-8. PubMed ID: 15955168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Favorable outcome of renal transplantation in patients with IgA nephropathy.
    Andresdottir MB; Hoitsma AJ; Assmann KJ; Wetzels JF
    Clin Nephrol; 2001 Oct; 56(4):279-88. PubMed ID: 11680657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The fate of glomerular mesangial IgA deposition in the donated kidney after allograft transplantation.
    Ji S; Liu M; Chen J; Yin L; Sha G; Chen H; Liu Z; Li L
    Clin Transplant; 2004 Oct; 18(5):536-40. PubMed ID: 15344956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term course of post-transplant mesangial IgA deposition: clinicopathologic study of nine cases.
    Hara S; Yamaguchi Y; Hara S; Tanimoto A; Seki K; Matsushita H; Tomikawa S; Kuzuhara K
    Clin Transplant; 2005; 19 Suppl 14():32-40. PubMed ID: 15955167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrence of IgA nephropathy among renal allograft recipients from living donors is greater among those with zero HLA mismatches.
    McDonald SP; Russ GR
    Transplantation; 2006 Sep; 82(6):759-62. PubMed ID: 17006322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for graft loss in patients with recurrent IGA nephropathy after renal transplantation.
    Namba Y; Oka K; Moriyama T; Ichimaru N; Kyo M; Kokado Y; Ito T; Imai E; Aozasa K; Okuyama A; Takahara S
    Transplant Proc; 2004 Jun; 36(5):1314-6. PubMed ID: 15251321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A clinicopathological study of recurrent IgA nephropathy following renal transplantation].
    Matsugami K; Naito T; Nitta K; Nihei H; Tanabe K; Toma H; Yamaguchi Y
    Nihon Jinzo Gakkai Shi; 1998 Jul; 40(5):322-8. PubMed ID: 9752688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The fate of renal transplants in patients with IgA nephropathy.
    Frohnert PP; Donadio JV; Velosa JA; Holley KE; Sterioff S
    Clin Transplant; 1997 Apr; 11(2):127-33. PubMed ID: 9113449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent mesangial IgA nephritis following renal transplantation.
    Odum J; Peh CA; Clarkson AR; Bannister KM; Seymour AE; Gillis D; Thomas AC; Mathew TH; Woodroffe AJ
    Nephrol Dial Transplant; 1994; 9(3):309-12. PubMed ID: 8052439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteinuria-reducing effects of tonsillectomy alone in IgA nephropathy recurring after kidney transplantation.
    Kennoki T; Ishida H; Yamaguchi Y; Tanabe K
    Transplantation; 2009 Oct; 88(7):935-41. PubMed ID: 19935466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latent IgA deposition from donor kidneys does not affect transplant prognosis, irrespective of mesangial expansion.
    Sofue T; Inui M; Hara T; Moritoki M; Nishioka S; Nishijima Y; Moriwaki K; Hayashida Y; Ueda N; Kushida Y; Haba R; Nishiyama A; Kakehi Y; Kohno M
    Clin Transplant; 2013; 27 Suppl 26():14-21. PubMed ID: 24299231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent IgA nephropathy in renal transplant allografts.
    Wang AY; Lai FM; Yu AW; Lam PK; Chow KM; Choi PC; Lui SF; Li PK
    Am J Kidney Dis; 2001 Sep; 38(3):588-96. PubMed ID: 11532693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrence of IgA nephropathy and Henoch-Schönlein purpura after kidney transplantation: risk factors and graft survival.
    Soler MJ; Mir M; Rodriguez E; Orfila A; Munne A; Vázquez S; Lloveras J; Puig JM
    Transplant Proc; 2005 Nov; 37(9):3705-9. PubMed ID: 16386512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgA nephropathy recurs early in the graft when assessed by protocol biopsy.
    Ortiz F; Gelpi R; Koskinen P; Manonelles A; Räisänen-Sokolowski A; Carrera M; Honkanen E; Grinyó JM; Cruzado JM
    Nephrol Dial Transplant; 2012 Jun; 27(6):2553-8. PubMed ID: 22167589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent or de novo IgA nephropathy with crescent formation after renal transplantation.
    Tang Z; Ji SM; Chen DR; Wen JQ; Chen JS; Liu ZH; Li LS
    Ren Fail; 2008; 30(6):611-6. PubMed ID: 18661411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of interleukin-10 gene G-1082A polymorphism on recurrent IgA nephropathy.
    Bantis C; Heering PJ; Aker S; Schwandt C; Grabensee B; Ivens K
    J Nephrol; 2008; 21(6):941-6. PubMed ID: 19034880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long term outcome of renal allografts in patients with immunoglobulin A nephropathy.
    Ng YS; Vathsala A; Chew ST; Chiang GS; Woo KT
    Med J Malaysia; 2007 Jun; 62(2):109-13. PubMed ID: 18705440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgA nephropathy in kidney allograft recipients-therapeutic perspective.
    Pazik J; Baczkowska T; Lewandowski Z; Lewandowska D; Ostrowska J; Perkowska Ptasińska A; Mróz A; Miszewska-Szyszkowska D; Rowinski W; Durlik M
    Transplant Proc; 2006; 38(1):112-4. PubMed ID: 16504678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does angiotensin blockade influence graft outcome in renal transplant recipients with IgA nephropathy?
    Courtney AE; McNamee PT; Nelson WE; Maxwell AP
    Nephrol Dial Transplant; 2006 Dec; 21(12):3550-4. PubMed ID: 16968729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Present status of ABO-incompatible kidney transplantation in Japan.
    Takahashi K; Saito K
    Xenotransplantation; 2006 Mar; 13(2):118-22. PubMed ID: 16623804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.